Nirrin Technologies Showcases Next-Generation Bioprocess Analytical Platform and Workflows at BPI Conference and Exhibition

Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, will showcase its Tunable Laser Near-Infrared (TL-NIR) platform at the BPI Conference & Exhibition, September 22–25 in Boston, at Booth #831. The TL-NIR platform combines a common hardware foundation with software-enabled analytical workflows, including TALOS™ rapid protein quantitation and ATLAS® multi-analyte quantitation. It is available as an at-line or in-line system, both of which support multiple software workflows. The in-line system can be configured with either a flow cell or in situ probe modality.

Niron Magnetics Marks Steel Raising at Sartell Manufacturing Site

Niron Magnetics, the company commercializing the world’s only high-performance rare-earth-free permanent magnets, celebrated the steel raising Wednesday at its manufacturing facility in Sartell, Minnesota, and announced an investment from Honda Motor Co., Ltd. (“Honda”).

6K Energy Signs MOU with Valgotech for Domestic NMC Supply

Valgotech LLC, a U.S. developer of advanced battery systems for defense and commercial applications, announced a new hybrid battery pack architecture designed to optimize the high energy-density advantages of lithium-metal and lithium-ion battery technologies.

NTx Bio Powers Baylor College of Medicine’s Manufacturing of a Personalized Cancer Vaccine in Diakonos Oncology’s Phase 1 Refractory Melanoma Trial

NTx Bio, a leader in next-generation biomanufacturing technologies, announced that its NTxscribe® CORE platform is being used by researchers at Baylor College of Medicine to manufacture mRNA for a personalized dendritic cell vaccine (DCV) now in clinical use in an industry-sponsored Phase 1 trial for refractory melanoma, marking one of the first publicly disclosed clinical translations of NTx’s continuous-flow manufacturing platform.

BioSkryb Genomics Names William E. Evans, Pharm.D. as Chief Executive Officer

BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of its Scientific Advisory Board since 2019. He succeeds Suresh Pisharody, who has departed the company to pursue other opportunities.

Euro Manganese Signs Offtake Term Sheet with 6K Energy Following Preliminary Qualification of High-Purity Manganese

Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (OTC Pink: EUMNF) (FSE: E060) (the “Company” or “Euro Manganese” or “EMN”) is pleased to announce that it has entered into a non-binding offtake term sheet with 6K Energy, a leading U.S.-based producer of advanced cathode active materials (“CAM”), for the proposed sale of high-purity electrolytic manganese metal (“HPEMM”) from the Company’s Chvaletice Manganese Project (“Chvaletice” or the “Project”) in the Czech Republic.

Niron Magnets Receives Conditional $150 Million Department of War Commitment

Niron Magnetics, the company commercializing the world’s first rare-earth-free Iron Nitride permanent magnets, today announced a conditional commitment from the Department of War’s Office of Strategic Capital (OSC) for a direct loan of up to $150 million with a 20-year term to support construction and equipment for the company’s advanced manufacturing plant in Sartell, Minnesota. The financing would accelerate domestic production of Niron’s proprietary Iron Nitride permanent magnets, which do not require rare earth materials, and would expand domestic production of advanced permanent magnets.